dexamethasone cyclodextrin nanoparticle ophthalmic suspension (OCS-01) - Oculis
LEOPARD: Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects With Uveitis Related and Post Surgical Macular Edema (clinicaltrials.gov) - Jun 6, 2023 - P2 | N=24 | Recruiting | Sponsor: Quan Dong Nguyen | Not yet recruiting ➔ Recruiting | Trial primary completion date: Jan 2024 ➔ Apr 2024 
Enrollment open • Trial primary completion date • Macular Edema • Ocular Inflammation • Ophthalmology • Uveitis
http://clinicaltrials.gov/ct2/show/NCT05608837
 
Jun 6, 2023
 
Prev Next